Literature DB >> 8373180

Purification and characterization of human serum hyaluronidase.

A M Afify1, M Stern, M Guntenhöner, R Stern.   

Abstract

Hyaluronidase from fresh human serum was purified to apparent homogeneity in a two-step procedure. Potent serum inhibitors of hyaluronidase activity were removed during the course of the purification. Isolation of the enzyme was expedited by the use of a newly devised ELISA-like assay. Enzyme activity was measured by following the rates of hydrolysis of hyaluronan (HA) adsorbed onto microtiter wells. Following enzymatic digestion, the remaining HA was measured using a cartilage-derived biotinylated HA-binding protein and an avidin-peroxidase reaction. Molecular sieve chromatography yielded a doublet of proteins with apparent molecular sizes of 42 and 50 kDa. The molecular size of the major band of protein obtained on sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing conditions was 59 kDa. Under reducing conditions, however, the size increased to 72 kDa. The pH optimum of the enzyme was 3.7. Sodium chloride concentrations greater than 100 mM were inhibitory. Activity of the serum enzyme was further characterized with a new HA-substrate gel procedure. The serum enzyme activity is different from the liver-derived activity. The tissue source of this circulating enzyme is unknown.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373180     DOI: 10.1006/abbi.1993.1443

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  23 in total

1.  Reverse hyaluronan substrate gel zymography procedure for the detection of hyaluronidase inhibitors.

Authors:  K Mio; R Stern
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

2.  Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome.

Authors:  Leslie B Gordon; Ingrid A Harten; Anthony Calabro; Geetha Sugumaran; Antonei B Csoka; W Ted Brown; Vincent Hascall; Bryan P Toole
Journal:  Hum Genet       Date:  2003-05-01       Impact factor: 4.132

3.  Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent.

Authors:  Liora Shiftan; Michal Neeman
Journal:  Contrast Media Mol Imaging       Date:  2006 May-Jun       Impact factor: 3.161

Review 4.  Hyaluronidases--a group of neglected enzymes.

Authors:  G Kreil
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

5.  A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase.

Authors:  Hayato Yamamoto; Yuki Tobisawa; Toshihiro Inubushi; Fumitoshi Irie; Chikara Ohyama; Yu Yamaguchi
Journal:  J Biol Chem       Date:  2017-02-28       Impact factor: 5.157

6.  Effect of anticoagulants on the plasma hyaluronidase activities.

Authors:  R Sharma; Y H Mahadeswaraswamy; K Harish Kumar; S Devaraja; K Kemparaju; B S Vishwanath; K S Girish
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 7.  Allergic reaction to hyaluronidase after retrobulbar anaesthesia: a case series and review.

Authors:  L Delaere; T Zeyen; B Foets; J Van Calster; I Stalmans
Journal:  Int Ophthalmol       Date:  2008-09-11       Impact factor: 2.031

8.  Novel products in hyaluronan digested by bovine testicular hyaluronidase.

Authors:  Fengchao Chen; Ikuko Kakizaki; Masanori Yamaguchi; Kaoru Kojima; Keiichi Takagaki; Masahiko Endo
Journal:  Glycoconj J       Date:  2008-11-15       Impact factor: 2.916

Review 9.  TMEM2: A missing link in hyaluronan catabolism identified?

Authors:  Yu Yamaguchi; Hayato Yamamoto; Yuki Tobisawa; Fumitoshi Irie
Journal:  Matrix Biol       Date:  2018-03-27       Impact factor: 11.583

10.  Isoenzyme-specific differences in the degradation of hyaluronic acid by mammalian-type hyaluronidases.

Authors:  Edith S A Hofinger; Julia Hoechstetter; Martin Oettl; Günther Bernhardt; Armin Buschauer
Journal:  Glycoconj J       Date:  2007-07-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.